Sinopharm
1099.HK
#1780
Rank
$7.46 B
Marketcap
$2.39
Share price
2.42%
Change (1 day)
7.66%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2021: $3.25 B

According to Sinopharm's latest financial reports the company's current earnings (TTM) are $3.25 B. In 2021 the company made an earning of $3.25 B an increase over its 2020 earnings that were of $2.91 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2021

Annual earnings

Year Earnings Change
2021$3.25 B11.7%
2020$2.91 B18.44%
2019$2.46 B3.48%
2018$2.37 B21.09%
2017$1.96 B24.41%
2016$1.57 B7.8%
2015$1.46 B11.65%
2014$1.31 B25.05%
2013$1.04 B22.72%
2012$0.85 B32.34%
2011$0.64 B55.56%
2010$0.41 B56.57%
2009$0.26 B34.55%
2008$0.19 B48.07%
2007$0.13 B123.29%
2006$59.63 M